Your Article Summary
See Latest ArticlesSimilar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 06/30/09
Rosenstock J et al. - The study shows no evidence of a greater risk of the development or progression of diabetic retinopathy with insulin glargine vs NPH insulin treatment in patients with type 2 diabetes mellitus.
Related Articles
Glyceraldehyde 3 phosphate dehydrogenase in retinal microvasculature: Implications for the development and progression of diabetic retinopathy
Investigative Ophthalmology and Visual Science, 11/18/09
Relevance Score: 69%
Identification of independent risk factors for the development of diabetic retinopathy requiring treatment
Acta Ophthalmologica, 11/18/09
Relevance Score: 69%
Diabetic Retinopathy Screening Update
Clinical Diabetes, 10/19/09
Relevance Score: 69%
Retinopathy - screening recommendations
Australian Family Physician, 10/06/09
Relevance Score: 69%
Micronutrients and Diabetic Retinopathy: A Systematic Review
Ophthalmology, 11/10/09
Relevance Score: 67%
Today in Retina...keeping you current
Receive free subspecialty "5-minute updates" via email
Inhibition of Benzo(e)Pyrene, a Toxic Component of Cigarette Smoke, Induced Apoptosis on Human Retinal Pigment Epithelial Cells In Vitro
Investigative Ophthalmology and Visual Science, 12/11/09
A new HLA extended haplotype containing the A 2910 allele is also associated with birdshot retinochoroidopathy and narrows susceptibility to the disease to the HLA molecule itself
Investigative Ophthalmology and Visual Science, 12/11/09
Time-Lapse Imaging of Retinal Angiogenesis Reveals Decreased Development and Progression of Neovascular Sprouting Treated with Anecortave Desacetate
Investigative Ophthalmology and Visual Science, 12/11/09